The findings of the research are scheduled to be presented at the American Society of Clinical Oncology (ASCO) annual meeting 2016 in Chicago. “Not all chemotherapy drugs cause neuropathy, but 60 per cent of people with breast cancer and other solid tumours who receive taxanes, vinca alkaloids and platinum-based chemotherapies will likely suffer this type of side effect,” Kleckner said. “Neuropathy is more commonly associated with diabetes or nerve damage. No US food and drug administration approved drugs are available to prevent or treat chemotherapy-induced neuropathy,” he added. “Exercise is like a sledgehammer because it affects so many biological and psycho-social pathways at the same time – brain circuitry, inflammation, our social interactions — whereas drugs usually have a specific target,” Kleckner said.